International Journal of Molecular Sciences (Apr 2021)

NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid Leukemia

  • Vincenza Barresi,
  • Virginia Di Bella,
  • Nellina Andriano,
  • Anna Provvidenza Privitera,
  • Paola Bonaccorso,
  • Manuela La Rosa,
  • Valeria Iachelli,
  • Giorgia Spampinato,
  • Giulio Pulvirenti,
  • Chiara Scuderi,
  • Daniele F. Condorelli,
  • Luca Lo Nigro

DOI
https://doi.org/10.3390/ijms22094575
Journal volume & issue
Vol. 22, no. 9
p. 4575

Abstract

Read online

Conventional chemotherapy for acute myeloid leukemia regimens generally encompass an intensive induction phase, in order to achieve a morphological remission in terms of bone marrow blasts (SPINK2, TMA7, SPCS2, CDCP1, CAPZA1, FGFR1OP2, MAN1A2, NT5C3A and SRP54. In conclusion, the integrated analysis of NUP98 mutational analysis and transcriptome profiles allowed the identification of novel putative biomarkers for the prediction of PIF in AML.

Keywords